4//SEC Filing
Markowitz Wayne 4
Accession 0001225208-24-005883
CIK 0001099800other
Filed
May 8, 8:00 PM ET
Accepted
May 9, 7:36 PM ET
Size
10.0 KB
Accession
0001225208-24-005883
Insider Transaction Report
Form 4
Markowitz Wayne
GM & SVP, Surgical
Transactions
- Award
Common Stock
2024-05-07+3,350→ 10,648.555 total - Award
Performance Rights
2024-05-07+3,350→ 3,350 totalFrom: 2027-05-07→ Common Stock (3,350 underlying) - Award
Employee Stock Option (Right to Acquire)
2024-05-07+17,800→ 17,800 totalExercise: $85.84From: 2025-05-07Exp: 2031-05-06→ Common Stock (17,800 underlying)
Footnotes (3)
- [F1]These restricted stock units were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.
- [F2]These options were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.
- [F3]Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2027. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards.
Documents
Issuer
Edwards Lifesciences Corp
CIK 0001099800
Entity typeother
Related Parties
1- filerCIK 0001991414
Filing Metadata
- Form type
- 4
- Filed
- May 8, 8:00 PM ET
- Accepted
- May 9, 7:36 PM ET
- Size
- 10.0 KB